Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Maryam Fattahian, Mustafa Ghanadian, Behzad Zolfaghari, Sara Abdeyazdan, Sedigheh Saberi, Fazila Zulfiqar, Ikhlas A. Khan & Zulfiqar Ali. (2022) Phytochemical study of Seriphidium khorassanicum (syn. Artemisia khorassanica) aerial parts: sesquiterpene lactones with anti-protozoal activity. Natural Product Research 0:0, pages 1-12.
Read now
Read now
Natascia Bruni, Barbara Stella, Leonardo Giraudo, Carlo Della Pepa, Daniela Gastaldi & Franco Dosio. (2017) Nanostructured delivery systems with improved leishmanicidal activity: a critical review. International Journal of Nanomedicine 12, pages 5289-5311.
Read now
Read now
H Van de Ven, J Vandervoort, W Weyenberg, S Apers & A Ludwig. (2012) Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation. Journal of Microencapsulation 29:2, pages 115-125.
Read now
Read now
Sheila J Thornton & Kishor M Wasan. (2009) The reformulation of Amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis. Expert Opinion on Drug Delivery 6:3, pages 271-284.
Read now
Read now
Articles from other publishers (35)
Harshita Sharma, Rakesh Sehgal, Sanjay Jhacak, Kirti Deshmukh & Ritambhara Nada. (2023) Evaluation of farnesol orally and topically against experimental cutaneous leishmaniasis: In -vivo analysis. PLOS ONE 18:8, pages e0290297.
Crossref
Crossref
Sweta Sharma, Prasanna Anjaneyulu Yakkala, Mirza A. Beg, Supriya Tanwar, Insha Latief, Arif Khan, Kalicharan Sharma, Sayeed ur Rehman, Angamuthu Selvapandiyan & Syed Shafi. (2023)
5‐Arylidene‐2,4‐thiazolidinediones as Cysteine Protease Inhibitors against
Leishmania Donovani
. ChemistrySelect 8:29.
Crossref
Crossref
Tanvi Goel, Deepali Bansode, Raihan Arikkattel Abdu & Sanal Dev. (2023) Molecular Docking, Microwave-Assisted Synthesis, Characterization and
Pharmacological Evaluation of 2,4,5-trisubstituted Imidazole’s. Current Microwave Chemistry 10:1, pages 43-52.
Crossref
Crossref
Patrick O. Sakyi, Samuel K. Kwofie, Julius K. Tuekpe, Theresa M. Gwira, Emmanuel Broni, Whelton A. MillerIIIIII, Michael D. Wilson & Richard K. Amewu. (2023) Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals 16:3, pages 330.
Crossref
Crossref
Nitin R. Rode, Aafaq A. Tantray, Amruta V. Shelar, Rajendra H. Patil & Santosh S. Terdale. (2022) Synthesis, anti-leishmanial screening, molecular docking, and ADME study of 1-amidoalkyl 2-naphthol derivatives catalyzed by amino acid ionic liquid. Research on Chemical Intermediates 48:6, pages 2391-2412.
Crossref
Crossref
Nicola S. Carter, Yumena Kawasaki, Surbhi S. Nahata, Samira Elikaee, Sara Rajab, Leena Salam, Mohammed Y. Alabdulal, Kelli K. Broessel, Forogh Foroghi, Alyaa Abbas, Reyhaneh Poormohamadian & Sigrid C. Roberts. (2022) Polyamine Metabolism in Leishmania Parasites: A Promising Therapeutic Target. Medical Sciences 10:2, pages 24.
Crossref
Crossref
Maria Simone Pereira Maciel, Aramys Silva dos Reis & Queli Cristina Fidelis. (2022) Antileishmanial potential of species from the family Lamiaceae: chemical and biological aspects of non-volatile compounds. Acta Tropica 228, pages 106309.
Crossref
Crossref
Nima Razzaghi-Asl & Niloufar Hashemi. (2022) Identification of potential antileishmanial agents via structure-based molecular simulations. Journal of Molecular Graphics and Modelling 110, pages 108039.
Crossref
Crossref
Ana Isabel Olías-Molero, Concepción de la Fuente, Montserrat Cuquerella, Juan J. Torrado & José M. Alunda. (2021) Antileishmanial Drug Discovery and Development: Time to Reset the Model?. Microorganisms 9:12, pages 2500.
Crossref
Crossref
Elahe Tajbakhsh, Ali Khamesipour, Seyed Reza Hosseini, Neda Kosari, Shima Shantiae & Faham Khamesipour. (2021) The effects of medicinal herbs and marine natural products on wound healing of cutaneous leishmaniasis: A systematic review. Microbial Pathogenesis 161, pages 105235.
Crossref
Crossref
Vikas Kushwaha & Sukhbir Kaur. (2021) Lymphatic filariasis and visceral leishmaniasis coinfection: A review on their epidemiology, therapeutic, and immune responses. Acta Tropica 224, pages 106117.
Crossref
Crossref
Patrick O. Sakyi, Richard K. Amewu, Robert N. O. A. Devine, Alfred K. Bienibuor, Whelton A. MillerIIIIII & Samuel K. Kwofie. (2021) Unravelling the myth surrounding sterol biosynthesis as plausible target for drug design against leishmaniasis. Journal of Parasitic Diseases 45:4, pages 1152-1171.
Crossref
Crossref
Tarun Mathur, Manoj Kumar, Tarani K Barman, V Samuel Raj, Dilip J Upadhyay & Ashwani K Verma. (2021) Novel azoles with potent antileishmanial activity. Future Microbiology 16:12, pages 871-877.
Crossref
Crossref
Santanu Sasidharan & Prakash Saudagar. (2021) Leishmaniasis: where are we and where are we heading?. Parasitology Research 120:5, pages 1541-1554.
Crossref
Crossref
Sahar Ghodsian, Niloofar Taghipour, Niloofar Deravi, Hamed Behniafar & Zohreh Lasjerdi. (2020) Recent researches in effective antileishmanial herbal compounds: narrative review. Parasitology Research 119:12, pages 3929-3946.
Crossref
Crossref
Bruno Mendes, Carolina Proaño-Bolaños, Fernanda R Gadelha, José R Almeida & Danilo C Miguel. (2020)
Cruzioseptins, antibacterial peptides from
Cruziohyla calcarifer
skin, as promising leishmanicidal agents
. Pathogens and Disease 78:6.
Crossref
Crossref
Fanny Mathias, Anita Cohen, Youssef Kabri, Núria Waddington Negrão, Maxime D. Crozet, Roberto Docampo, Nadine Azas & Patrice Vanelle. (2020) Synthesis and in vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents. European Journal of Medicinal Chemistry 191, pages 112146.
Crossref
Crossref
Rafael Dias do Espírito Santo, Ángela María Arenas Velásquez, Luana Vitorino Gushiken Passianoto, Alex Arbey Lopera Sepulveda, Leandro da Costa Clementino, Renata Pires Assis, Amanda Martins Baviera, Predrag Kalaba, Fábio Neves dos Santos, Marcos Nogueira Éberlin, Gil Valdo José da Silva, Martin Zehl, Gert Lubec, Márcia Aparecida Silva Graminha & Eduardo René Pérez González. (2019) N, N′, N″-trisubstituted guanidines: Synthesis, characterization and evaluation of their leishmanicidal activity. European Journal of Medicinal Chemistry 171, pages 116-128.
Crossref
Crossref
Adnan A. Bekhit, Eman El-Agroudy, Aliaa Helmy, Tamer M. Ibrahim, Amin Shavandi & Alaa El-Din A. Bekhit. (2018) Leishmania treatment and prevention: Natural and synthesized drugs. European Journal of Medicinal Chemistry 160, pages 229-244.
Crossref
Crossref
Fiaz Alam & Qazi Najam us Saqib. (2017) Evaluation of Zanthoxylum armatum Roxb for in vitro biological activities. Journal of Traditional and Complementary Medicine 7:4, pages 515-518.
Crossref
Crossref
Caroline Schad, Ulrike Baum, Benjamin Frank, Uwe Dietzel, Felix Mattern, Carlos Gomes, Alicia Ponte-Sucre, Heidrun Moll, Uta Schurigt & Tanja Schirmeister. (2016) Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases. Antimicrobial Agents and Chemotherapy 60:2, pages 797-805.
Crossref
Crossref
Rui M Lopes, Joana Pereira, M Alexandra Esteves, M Manuela Gaspar, Manuela Carvalheiro, Carla V Eleutério, Lídia Gonçalves, António Jiménez-Ruiz, António J Almeida & M Eugénia M Cruz. (2016)
Lipid-based nanoformulations of trifluralin analogs in the management of
Leishmania infantum
infections
. Nanomedicine 11:2, pages 153-170.
Crossref
Crossref
Luisa Ronga, Marco Del Favero, Anita Cohen, Claire Soum, Patrice Le Pape, Solène Savrimoutou, Noël Pinaud, Catherine Mullié, Sylvie Daulouede, Philippe Vincendeau, Natacha Farvacques, Patrice Agnamey, Fabrice Pagniez, Sébastien Hutter, Nadine Azas, Pascal Sonnet & Jean Guillon. (2014) Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents – Part III. European Journal of Medicinal Chemistry 81, pages 378-393.
Crossref
Crossref
Vikramdeep Monga, Kamya Goyal, Mario Steindel, Manav Malhotra, Dhanji P. Rajani & Smita D. Rajani. (2013) Synthesis and evaluation of new chalcones, derived pyrazoline and cyclohexenone derivatives as potent antimicrobial, antitubercular and antileishmanial agents. Medicinal Chemistry Research 23:4, pages 2019-2032.
Crossref
Crossref
Sophie Marhadour, Pascal Marchand, Fabrice Pagniez, Marc-Antoine Bazin, Carine Picot, Olivier Lozach, Sandrine Ruchaud, Maud Antoine, Laurent Meijer, Najma Rachidi & Patrice Le Pape. (2012) Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents. European Journal of Medicinal Chemistry 58, pages 543-556.
Crossref
Crossref
Dinorah Gambino. (2011) Potentiality of vanadium compounds as anti-parasitic agents. Coordination Chemistry Reviews 255:19-20, pages 2193-2203.
Crossref
Crossref
Nishi Shakya, Preeti Bajpai & Suman Gupta. (2011) Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs. Journal of Parasitic Diseases 35:2, pages 104-112.
Crossref
Crossref
Rupashree Sen & Mitali Chatterjee. (2011) Plant derived therapeutics for the treatment of Leishmaniasis. Phytomedicine 18:12, pages 1056-1069.
Crossref
Crossref
Daniel Plano, Ylenia Baquedano, David Moreno-Mateos, María Font, Antonio Jiménez-Ruiz, Juan Antonio Palop & Carmen Sanmartín. (2011) Selenocyanates and diselenides: A new class of potent antileishmanial agents. European Journal of Medicinal Chemistry 46:8, pages 3315-3323.
Crossref
Crossref
David Moreno, Daniel Plano, Ylenia Baquedano, Antonio Jiménez-Ruiz, Juan Antonio Palop & Carmen Sanmartín. (2010) Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates. Parasitology Research 108:1, pages 233-239.
Crossref
Crossref
Andrés F Flórez, Daeui Park, Jong Bhak, Byoung-Chul Kim, Allan Kuchinsky, John H Morris, Jairo Espinosa & Carlos Muskus. (2010) Protein network prediction and topological analysis in Leishmania major as a tool for drug target selection. BMC Bioinformatics 11:1.
Crossref
Crossref
Xuanmao Chen, Beverley A. Orser & John F. MacDonald. (2010) Design and screening of ASIC inhibitors based on aromatic diamidines for combating neurological disorders. European Journal of Pharmacology 648:1-3, pages 15-23.
Crossref
Crossref
Simona John von Freyend, Heidi Rosenqvist, Annette Fink, Inga Maria Melzer, Joachim Clos, Ole Nørregaard Jensen & Martin Wiese. (2010) LmxMPK4, an essential mitogen-activated protein kinase of Leishmania mexicana is phosphorylated and activated by the STE7-like protein kinase LmxMKK5. International Journal for Parasitology 40:8, pages 969-978.
Crossref
Crossref
Andrea Cavalli & Maria Laura Bolognesi. (2009)
Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against
Trypanosoma
and
Leishmania
. Journal of Medicinal Chemistry 52:23, pages 7339-7359.
Crossref
Crossref
Jasmin Ryczak & Conrad Kunick. (2009) Wirkstoffe zur Behandlung von Leishmaniosen. Antimon und mehr. Pharmazie in unserer Zeit 38:6, pages 538-544.
Crossref
Crossref